Article
IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance.
The pharmacogenomics journal - 1 Oct 2007
Roberts R L, Gearry R B, Barclay M L, Kennedy M A
Abstract excerpt
Around 9% of inflammatory bowel disease (IBD) patients are resistant to azathioprine. We hypothesized that these patients may carry mutations within inosine-5'-monophosphate dehydrogenase (IMPDH). To test this hypothesis, we screened 20 azathioprine-resistant patients for variations in the two IMPDH genes (IMPDH1 and IMPDH2) using dHPLC and DNA sequencing. A 9 bp insertion within the IMPDH1 P3 promoter was found...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
